OXAPROZIN TAB,ORAL

Continuity of Care Inclusion Criteria

• Veteran is transitioning care from the Department of Defense to VHA (must be met along with one Additional Inclusion Criterion)
• Additional Inclusion Criteria (Select ONE if appropriate)
• The medication is safe and clinically appropriate as determined by a VA prescriber using shared decision making
• The medication is indicated for tapering the dose or slowly discontinuing therapy as determined by a VA prescriber using shared decision making
• Non-Continuity of Care Inclusion Criteria (All criteria must be met)
• Inadequate response or intolerance to two formulary NSAIDs